Stephen Hill
Chief Operating Officer at LYELL IMMUNOPHARMA, INC.
Net worth: 19 909 $ as of 2024-03-30
Profile
Stephen Hill is currently the Chief Operating Officer at Lyell Immunopharma, Inc. He previously worked as the Vice President-Bulk Manufacturing at Amgen, Inc. and as the SVP & Head-Global Biologics Operations at AstraZeneca PLC.
Mr. Hill received his undergraduate degree and MBA from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC.
0.00% | 2024-02-08 | 8,928 ( 0.00% ) | 19 909 $ | 2024-03-30 |
Stephen Hill active positions
| Companies | Position | Start |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Chief Operating Officer | 2021-10-31 |
Former positions of Stephen Hill
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2019-05-31 |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Stephen Hill
| University of Washington | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
- Stock Market
- Insiders
- Stephen Hill
